A Systematic Review of Clinical Practice Guidelines for Managing Pulmonary Toxicities Caused by Immune Checkpoint Inhibitors: Quality of Treatment Recommendations and Differences in Management Strategies Between Guidelines

BACKGROUND: Pulmonary toxicities caused by immune checkpoint inhibitors are a prominent concern for clinicians. Clinical Practice Guidelines (CPGs) are critical for managing these toxicities. METHODS: A systematic search of CPGs on checkpoint-associated pulmonary toxicities (ca-PT) was conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Donkor, Kofi N, Jang, Hyeree, Sail, Reena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683390/
https://www.ncbi.nlm.nih.gov/pubmed/38033741
http://dx.doi.org/10.1177/11795549231203153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683390/
https://www.ncbi.nlm.nih.gov/pubmed/38033741
http://dx.doi.org/10.1177/11795549231203153

Ejemplares similares